Epithelioid Mesothelioma
📧 Sign up to get email alerts when something new happens for Epithelioid Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pembrolizumab in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating pembrolizumab in malignant mesothelioma and related subtypes; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors [Phase 1]
Phase 1 trial evaluating LMB-100 with tofacitinib in previously treated mesothelin-expressing solid tumors, including pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pemetrexed disodium with cisplatin, with or without cediranib, in malignant pleural mesothelioma; result…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 trial of tivantinib in previously treated malignant mesothelioma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial update for belinostat (PXD101) as second-line therapy in unresectable malignant mesothelioma; study completed with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. [Phase 2]
Phase 2 trial update of sorafenib tosylate in malignant mesothelioma has completed (status: COMPLETED).